|
IFT74 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.418700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.377000E-03 |
| Normal-vs-Stage2 |
6.239400E-03 |
| Normal-vs-Stage3 |
6.378200E-04 |
| Normal-vs-Stage4 |
2.598500E-02 |
| Stage1-vs-Stage2 |
7.425400E-01 |
| Stage1-vs-Stage3 |
4.341600E-01 |
| Stage1-vs-Stage4 |
8.598800E-01 |
| Stage2-vs-Stage3 |
7.362400E-01 |
| Stage2-vs-Stage4 |
9.452400E-01 |
| Stage3-vs-Stage4 |
7.181400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.156640E-03 |
| Normal-vs-AfricanAmerican |
4.118500E-03 |
| Normal-vs-Asian |
2.298800E-01 |
| Caucasian-vs-AfricanAmerican |
6.255600E-01 |
| Caucasian-vs-Asian |
6.865000E-01 |
| AfricanAmerican-vs-Asian |
7.913800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.832400E-04 |
| Normal-vs-Female |
4.978100E-02 |
| Male-vs-Female |
3.346300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.715000E-03 |
| Normal-vs-Extreme_Weight |
3.449800E-04 |
| Normal-vs-Obese |
1.650240E-02 |
| Normal-vs-Extreme_Obese |
8.761300E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.726000E-01 |
| Normal_Weight-vs-Obese |
5.539000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.312600E-01 |
| Extreme_Weight-vs-Obese |
1.895650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.442000E-01 |
| Obese-vs-Extreme_Obese |
3.331200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.080400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.670240E-02 |
| Normal-vs-Age(61-80Yrs) |
5.7581999999945E-05 |
| Normal-vs-Age(81-100Yrs) |
5.495500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.412800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.629540E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.219900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.259800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.667960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.555400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.504000E-03 |
| Normal-VS-Type2 PRCC |
2.40659999999338E-05 |
| Normal-VS-KIRP CIMP |
9.544800E-01 |
| Normal-VS-Unclassified PRCC |
1.017490E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.242300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.396160E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.445700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.263760E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.405200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.560300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1722999999918E-05 |
| Normal-vs-N1 |
3.316100E-02 |
| Normal-vs-N2 |
3.055900E-02 |
| N0-vs-N1 |
1.398650E-01 |
| N0-vs-N2 |
7.568800E-01 |
| N1-vs-N2 |
3.647400E-01 |
|
|
